Control of oral anticoagulation in patients with the antiphospholipid syndrome - Influence of the lupus anticoagulant on International Normalized Ratio

Thrombosis and Haemostasis

Volumn 80, Issue 1, 1998, Pages 99-103

  Robert, A ^a   Le Querrec, A ^b   Delahousse, B ^b   Caron, C ^b   Houbouyan, L ^b   Boutiere B ^b   Horellou, M H ^b   Reber, G ^b   Sie P ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; LUPUS ANTICOAGULANT; PROTHROMBIN; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOANALYZER; CALIBRATION; CONTROLLED STUDY; DOSE CALCULATION; HUMAN; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; PROTHROMBIN TIME;

EID: 0031927812     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615146     Document Type: Article

References (14)

1. Derksen RHWM, de Groot PG, Kater L et al. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993; 52: 689-92.
2. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Int Med 1992; 117: 303-8.
3. Khamashta MA, Cuadrado MJ, Mujie F et al. The management of thrombosis in the antiphospholipid syndrome. N Engl J Med 1995; 332: 993-7.
4. Palareti G, Coccheri S, Poggi M, Bonetti M, Cervi V, Mazzucca A, Savoia M, Veri L, Fiori F, Gaspari G, Palareti A. Oral anticoagulant control exercise. Thromb Haemost 1987; 58: 905-10.
5. Della Valle P, Crippa L, Safa O, Tomassini L, Pattarini E, Vigano D'Angelo S, Sabbanini MG, D'Angelo A. Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann Med Intern 1996; 147: 10-4.
6. Moll S, Ortel TL. Monitoring Warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997; 127: 177-85.
7. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring oral anticoagulation therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Haematol 1997; 98: 887-92.
8. Finazzi G, Barbui T, for the International Steening Committee of the WAPS Study. Proposal of clinical trial of high dose warfarin in the anti-phospholipid syndrome: the WAPS Study. Lupus 1996; 5: 556.
9. Working Group on Haemostasis of the Société Française de Biologie Clinique. Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Thromb Haemost 1993; 70: 781-6.
10. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-90.
11. Hubbard AR, Margetts SML, Barrowcliffe TW. International normalized ratio determination using calibrated reference plasmas. Br J Haematol 1997; 98: 74-8.
12. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-7.
13. The Le D, Weibert RT, Sevilla BK, Donnely KJ, Rapaport SI. The International Normalized ratio (INR) for monitoring warfarin therapy: relability and relation to other monitoring methods. Ann Intern Med 1994; 120: 552-8.
14. Tripodi A, Arbini A, Chantarangkul V, Mannucci PM. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test. Thromb Haemost 1992; 67: 42-5.